Succinate Mediates Tumorigenic Effects via Succinate Receptor 1: Potential for New Targeted Treatment Strategies in Succinate Dehydrogenase Deficient Paragangliomas.
Matlac DM, Hadrava Vanova K, Bechmann N, Richter S, Folberth J, Ghayee HK, Ge GB, Abunimer L, Wesley R, Aherrahrou R, Dona M, Martínez-Montes ÁM, Calsina B, Merino MJ, Schwaninger M, Deen PMT, Zhuang Z, Neuzil J, Pacak K, Lehnert H, Fliedner SMJ.
Matlac DM, et al. Among authors: wesley r.
Front Endocrinol (Lausanne). 2021 Mar 12;12:589451. doi: 10.3389/fendo.2021.589451. eCollection 2021.
Front Endocrinol (Lausanne). 2021.
PMID: 33776908
Free PMC article.